Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 15601-15650 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06738992
Safety and Effectiveness of Early Aspirin Administration After Mitral Valve Repair
PHASE4Recruiting
384 participants
Started: Nov 14, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06344949
Ciprofol Versus Propofol for Tracheal Intubation in ICU
PHASE4Recruiting
100 participants
Started: Nov 14, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06637332
Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
PHASE4Recruiting
300 participants
Started: Nov 14, 2024 · Completed: Nov 30, 2027
5 conditions3 sponsors13 locations
NCT06474598
An Adaptive Design Study of MTX228
PHASE2Recruiting
24 participants
Started: Nov 14, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06335199
tVNS Responsiveness Testing With Pupil Size
NARecruiting
21 participants
Started: Nov 14, 2024 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT06895447
Robotic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Therapy
PHASE2Recruiting
40 participants
Started: Nov 14, 2024 · Completed: Dec 30, 2028
1 condition5 sponsors1 location
NCT06648772
Efficacy and Safety of Roflumilast Cream 0.3% in Subjects With Plaque Psoriasis: a Phase 3 Study
PHASE3Recruiting
189 participants
Started: Nov 14, 2024 · Completed: Jul 4, 2025
1 condition1 sponsor31 locations
NCT06415175
Study in Paediatric Patients With Atopic Dermatitis Treated With Dupilumab in Spain
N/ARecruiting
150 participants
Started: Nov 14, 2024 · Completed: Nov 23, 2027
1 condition2 sponsors15 locations
NCT07110311
Impact of Pet Cats on Nasal and Gut Microbiota in Patients With Cat Allergen Allergy
N/ARecruiting
100 participants
Started: Nov 14, 2024 · Completed: Nov 1, 2032
1 condition1 sponsor1 location
NCT06264843
Peripheral Bypass Trial for Completion Control
N/ARecruiting
450 participants
Started: Nov 14, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06680232
Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B
PHASE1Recruiting
45 participants
Started: Nov 14, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor4 locations
NCT06490445
A Study of Medical Cannabis Aerosol Via the Fixed-dose Syqe Inhaler as an Add-on Treatment of Diabetic Peripheral Neuropathic Pain (DPNP)
PHASE2Recruiting
192 participants
Started: Nov 14, 2024 · Completed: Nov 8, 2025
1 condition1 sponsor38 locations
NCT06461650
Preoperative Nicotine Cessation for Women With Breast Cancer Recommended for Reconstruction
NARecruiting
20 participants
Started: Nov 14, 2024 · Completed: Mar 31, 2029
1 condition1 sponsor1 location
NCT06732219
A Single-Arm Pilot Trial for Mitigating Relapse of Severe Problem Behavior
NARecruiting
10 participants
Started: Nov 14, 2024 · Completed: Aug 31, 2026
1 condition2 sponsors2 locations
NCT06486467
Reliability of Minimally Trained Operator's Velocity-Time Integral Measurement Guided by Artificial Intelligence VTI
NARecruiting
100 participants
Started: Nov 14, 2024 · Completed: Sep 1, 2025
3 conditions3 sponsors3 locations
NCT06512558
Augmented Reality Feasibility for Non-invasive Preoperative Tracking in Breast Cancer Surgery
NARecruiting
10 participants
Started: Nov 14, 2024 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT06452706
The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer
PHASE2Recruiting
42 participants
Started: Nov 14, 2024 · Completed: Jun 30, 2028
1 condition1 sponsor16 locations
NCT06728189
A Clinical Research About CD70-targeted CAR-NKT Cells Therapy in Subjects with Advanced Malignant Solid Tumors
PHASE1Recruiting
13 participants
Started: Nov 14, 2024 · Completed: Oct 17, 2026
1 condition2 sponsors1 location
NCT06555432
A Study of LIVTENCITY (Maribavir) in Adults With Cytomegalovirus (CMV) Infection After Transplantation in South Korea
N/ARecruiting
168 participants
Started: Nov 14, 2024 · Completed: Oct 1, 2028
1 condition1 sponsor1 location
NCT06711471
Trifluridine/tipiracil (TAS-102), Bevacizumab, and Camrelizumab As Third-line or Later-line Therapy of Gastric Cancer
PHASE2Recruiting
31 participants
Started: Nov 14, 2024 · Completed: Nov 13, 2027
1 condition1 sponsor1 location
NCT06835855
Development of Attentional Biases for Affective Cues in Infants of Mothers With Depression
NARecruiting
225 participants
Started: Nov 14, 2024 · Completed: Jul 31, 2029
1 condition2 sponsors1 location
NCT06518564
Avelumab and M1774 in ARID1A-mutated Endometrial Cancer
PHASE2Recruiting
25 participants
Started: Nov 14, 2024 · Completed: Aug 31, 2029
3 conditions3 sponsors2 locations
NCT06422923
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
PHASE1/PHASE2Recruiting
10 participants
Started: Nov 14, 2024 · Completed: Jun 15, 2042
1 condition1 sponsor17 locations
NCT06527521
Prevalence of Amyloidosis in Trauma Patients
N/ARecruiting
246 participants
Started: Nov 13, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06617832
Trial Designs for Evaluating Migraine Treatment
NARecruiting
128 participants
Started: Nov 13, 2024 · Completed: Sep 30, 2028
3 conditions1 sponsor2 locations
NCT06607627
PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis
PHASE3Recruiting
12 participants
Started: Nov 13, 2024 · Completed: Jul 18, 2029
2 conditions1 sponsor12 locations
NCT06915168
CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer
NARecruiting
20 participants
Started: Nov 13, 2024 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT06689865
Innovations in Hearing Accessibility and Technology (IHAT) Study
NARecruiting
280 participants
Started: Nov 13, 2024 · Completed: Mar 31, 2029
3 conditions2 sponsors2 locations
NCT06670521
Corticosteroids for Post-Extubation Dysphagia
PHASE2Recruiting
80 participants
Started: Nov 13, 2024 · Completed: May 31, 2027
2 conditions2 sponsors1 location
NCT06222333
Breathing Exercise for Rib Fracture
NARecruiting
62 participants
Started: Nov 13, 2024 · Completed: Apr 1, 2026
2 conditions1 sponsor1 location
NCT05979818
Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer
PHASE1Recruiting
6 participants
Started: Nov 13, 2024 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT06668194
Effect of Force Magnitude on Canine Retraction and Gingival Crevicular Fluid Proteome
NARecruiting
40 participants
Started: Nov 13, 2024 · Completed: Apr 1, 2028
1 condition2 sponsors1 location
NCT06690827
Clinical Trial of CD123-targeted CAR-NK Therapy for Relapse/refractory AML or BPDCN
PHASE1Recruiting
30 participants
Started: Nov 13, 2024 · Completed: Oct 30, 2028
2 conditions1 sponsor1 location
NCT06685068
A Phase 1/2 Study of GEN1286 in Patients With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
260 participants
Started: Nov 13, 2024 · Completed: Jun 29, 2028
1 condition1 sponsor4 locations
NCT06546007
Rarecells Molecular Biomarkers for Early Detection of Lung Cancer
N/ARecruiting
50 participants
Started: Nov 13, 2024 · Completed: Oct 1, 2025
2 conditions3 sponsors1 location
NCT06830811
Bone Mineral Density Precision Study
NARecruiting
30 participants
Started: Nov 13, 2024 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT06692751
The Value of Measuring Retinal Vascular Density by Optical Coherence Tomography-Angiography (OCT-A) in Patients with Microvascular Angina Confirmed by Myocardial Microcirculatory Resistance Index (MRI).
N/ARecruiting
158 participants
Started: Nov 13, 2024 · Completed: Nov 30, 2027
1 condition1 sponsor1 location
NCT06511037
PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis
EARLY_PHASE1Recruiting
10 participants
Started: Nov 13, 2024 · Completed: Nov 30, 2026
2 conditions2 sponsors1 location
NCT06635226
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ID110521156 in Healthy Adult Subjects
PHASE1Recruiting
36 participants
Started: Nov 13, 2024 · Completed: Jun 19, 2025
1 condition2 sponsors1 location
NCT06646419
Boosting Regional Integration for COP D Care Through Guided Implementation and Audit of Post Exacerbation Transition Bundle
N/ARecruiting
1,368 participants
Started: Nov 13, 2024 · Completed: Aug 31, 2026
1 condition1 sponsor37 locations
NCT06460948
Identifying Oxytocin Deficiency in Adults With Pituitary Disease
EARLY_PHASE1Recruiting
32 participants
Started: Nov 13, 2024 · Completed: Jun 30, 2026
2 conditions1 sponsor1 location
NCT07091058
Harmful Algal Blooms
N/ARecruiting
400 participants
Started: Nov 13, 2024 · Completed: Jun 30, 2026
1 condition3 sponsors1 location
NCT06465641
Methylphenidate in KBG Syndrome: N-of-1 Series
PHASE4Recruiting
15 participants
Started: Nov 13, 2024 · Completed: Oct 1, 2027
2 conditions1 sponsor1 location
NCT06690411
Comparison of Myofascial Release and Mulligan Concept Techniques in Patients With Cervicogenic Headache
NARecruiting
40 participants
Started: Nov 13, 2024 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT06616532
PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer
PHASE3Recruiting
404 participants
Started: Nov 13, 2024 · Completed: Dec 25, 2028
1 condition1 sponsor45 locations
NCT06659952
HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients
NARecruiting
50 participants
Started: Nov 13, 2024 · Completed: Oct 31, 2034
2 conditions1 sponsor1 location
NCT06382012
Antiemetic Fosaprepitant To Remedy Nausea and Vomiting
PHASE2/PHASE3Recruiting
250 participants
Started: Nov 13, 2024 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT06912230
Hypoxia, Appetite, and Energy Intake in Young Female Adults
NARecruiting
10 participants
Started: Nov 13, 2024 · Completed: Dec 31, 2025
4 conditions4 sponsors1 location
NCT07024641
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection
PHASE1Recruiting
48 participants
Started: Nov 13, 2024 · Completed: Sep 30, 2027
1 condition1 sponsor11 locations
NCT06884358
Functional Capacity in Anderson-Fabry Disease Patients
N/ARecruiting
100 participants
Started: Nov 13, 2024 · Completed: Jan 31, 2032
1 condition1 sponsor5 locations